ClinicalTrials.gg
Drug

Ioflupane I-123 clinical trials

Also written DaTscan.

studies test it
6
open now
1
in phase 3
2
first study started
2003

How each study uses ioflupane I-123 is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the ioflupane I-123 studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Approvals

The first approval found in each region, with its record

United States
Not in FDA's approval records
European Union
27 Jul 2000 · DaTSCAN · EMEA/H/C/000266 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Brand

DaTscan
3

Studies by the year they started

6 studies that test it; most in 2003 (1)

Studies that test ioflupane I-123, by start year
YearStudies
20031
20091
20101
20111
20121
20171

By phase

A phase 1/2 study counts in both.

Phase 2
3
Phase 3
2
Phase 4
1

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 1 · Other 5

Ken Marek, MD (1) · University Hospital, Toulouse (1) · Assistance Publique - Hôpitaux de Paris (1) · GE Healthcare (1) · Mayo Clinic (1) · Region Skane (1)

Related medicines

As reviewed, each with the page that says it.

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 1

Studies that test ioflupane I-123.

Studies

Open first, then newest update. How each study uses ioflupane I-123 is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 6

Given beside what is tested · 1 — ioflupane I-123 is usual care or a partner of the new treatment
As the comparator · 1 — what is tested is compared with ioflupane I-123

Codes

What other systems call ioflupane I-123 · ClinicalTrials.gg INT014697

  • UNII (FDA) 3MM99T8R5QIOFLUPANE I-123Confirmed FDA, Wikidata
  • RxNorm 1426874Confirmed FDA, Wikidata
  • Wikidata Q3801359ioflupane I-123Confirmed FDA, Wikidata
  • NCI Thesaurus C80644Ioflupane I-123Confirmed FDA, Wikidata
  • DrugBank DB08824One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.